drugset / Trial / NCT04349722

The Effect of Hyoscine-N-butylbromide (HBB, Buscopan) in Augmented Labour Among Primigravidae

NCT04349722

Phase 4 Completed 110 enrolled National University of Malaysia
RandomizedParallel-groupDouble-blindTreatment

Summary

This study compares the duration of active phase of labour in women who received buscopan and those who don't.

Timeline

Start
2019-12-01
Primary completion
2020-06-30
Completion
2020-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hyoscine butylbromide Unknown 20 mg Intravenous

Indications

No indication recorded.